References
- Editorial Staff. Copper (Management/Treatment Protocol). POISINDEX® System, RK Klasco. Thomson Micromedex, Greenwood Village, Colorado 6/2006
- Bingham E, Cohrssen B, Powell CH. Patty's Toxicology 5th. John Wiley & Sons, New York 2001; 2
- Nelson L. Copper. Goldfrank's Toxicologic Emergencies 7th, LR Goldfrank, NE Flomenbaum, NA Lewin, RS Weisman, MA Howland, RS Hoffman. Appleton & Lange, New York 2002; 1262–1271
- Barranco VP. Eczematous dermatitis caused by internal exposure to copper. Arch Dermatol 1972; 106: 386–387
- Kurisaki E, Kuroda Y, Sato M. Copper-binding protein in acute copper poisoning. Forens Sci Internat 1988; 38: 3–11
- Dowdy RP. Copper metabolism. Am J Clin Nutr 1969; 22: 887–892
- Bentur Y, Koren G, McGuigan M. An unusual skin exposure to copper: Clinical and pharmacokinetic evalution. Clin Toxicol 1988; 26: 371–380
- Barceloux DG. Copper. Clin Toxicol 1999; 37: 217–230
- Metz EN, Sagone AL. The effect of copper on the erythrocyte hexose monophosphate shunt pathway. J Lab Clin Med 1972; 80: 405–413
- Owen CA, Jr, Randall RV, Goldstein NP. Effect of dietary D-penicillamine on metabolism of copper in the rat. Am J Physiol 1975; 228(1)88–91
- Bhusnurmath SR, Walia BNS, Singh S. Sequential histopathologic alterations in Indian childhood cirrhosis treated with d-Penicillamine. Human Pathol 1991; 22: 653–658
- Rodeck B, Kardoff R, Melter M. Treatment of copper associated liver disease in childhood. Eur J Med Res 1999; 4(6)253–6
- Mitchell WM, Basinger MA, Jones MM. Antagonism of acute copper(II)-induced renal lesions by sodium 2,3-dimercaptopropanesulfonate. Johns Hopkins Med J 1982; 151(6)283–5